Why Is Elementis PLC Up Today?
Elementis PLC shares rose 0.11% to 181.80p today, a gain of 0.20p, according to the supplied market data.
There was no new company announcement. The small gain comes as investors await Elementis's third-quarter trading update, typically released in late October.
The shares are supported by an ongoing c£25m share buyback launched after the sale of its pharmaceutical manufacturing business.
Key Highlights
H1 2026 revenue rose 4.7% to $318.2m.
Adjusted operating profit increased 16.4% to $73.2m, with margin rising to 23.0%.
Adjusted EPS rose 28.8% to 8.5 cents.
The interim dividend increased 15.4% to 1.5 cents.
Management expressed continued confidence in the full-year outlook.
About Elementis PLC
Elementis is a pure-play specialty chemicals company focused on additives for Personal Care and Coatings.
Its products include rheology modifiers that control the texture and flow of products such as cosmetics, antiperspirants and paints. A key raw material is hectorite clay, which Elementis mines in California.
LSE:ELM has simplified its portfolio by selling its Talc, chromium and pharmaceutical manufacturing businesses.
Key Reasons Behind Today's Uptick
With no news, the small rise appears to reflect routine trading and buyback support.
Investors may also be positioning ahead of the Q3 trading update, given the confident tone of the half-year results.
Specialty chemicals with high margins and pricing power have attracted interest as investors look for quality industrial businesses.
Elevate Elementis Strategy
Chief executive Luc van Ravenstein launched the 'Elevate Elementis' strategy in July 2025. It focuses on leveraging Elementis's differentiators, accelerating innovation and creating a simpler, leaner business.
One year in, he said real progress is coming through in the financial results. The group is on track to deliver total net savings of $4m by the end of 2026 and complete a targeted $10m net savings programme.
The medium-term target is mid-single-digit growth through the cycle.
Personal Care and Coatings
Personal Care's adjusted operating margin improved to 38.1%, partly helped by the acquisition of Alchemy, a fast-growing personal care specialist. Personal Care revenue rose 2.9% at constant currency.
Coatings led growth with revenue up 5.6% at constant currency, supported by Asia, EMEA, new applications and improved operations at its St Louis plant.
Portfolio Simplification
The sale of Talc completed in May 2025, and the pharmaceutical manufacturing business sale completed in June 2026. Elementis now has lower capital intensity, higher margins and stronger fundamentals for growth.
Net proceeds are funding the share buyback.
Why Hectorite Matters
Elementis owns one of the world's few commercial hectorite clay mines, located in California. Hectorite is a natural mineral used to thicken and stabilise products, particularly in cosmetics and personal care.
This gives Elementis a differentiated, hard-to-replicate raw material position, supporting pricing power and high margins in its Personal Care division.
Demand for natural and sustainable ingredients in beauty products also plays to this strength.
Coatings Additives
In Coatings, Elementis supplies additives that control the flow, levelling and performance of paints and industrial coatings. Its NiSAT additives target premium decorative coatings.
A local-for-local manufacturing strategy has helped reduce costs and improve resilience to tariffs and supply chain disruption.
Key Growth Catalysts
Innovation in personal care and coatings, growth in Asia, cost savings and buybacks support the outlook.
Risks
Weak industrial and consumer demand, raw material and energy costs, currency movements and tariffs are key risks.
Valuation
At 181.80p, Elementis has a market capitalisation of approximately £1.03bn.
Investors value Elementis on its earnings growth and margins, which have improved significantly following the portfolio changes.
What Investors Should Watch Next
Investors should watch the Q3 trading update, buyback progress, margin trends and full-year results in March 2027.
Conclusion
Elementis's 0.11% gain to 181.80p is modest. Strong margins, a simplified portfolio and buybacks support the investment case.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...